학술논문

Eculizumab(C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy (IMN): Preliminary baseline and pharmacokinetic(PK)/pharmacodynamic (PD) data.
Document Type
Journal
Source
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY; SEP 2002, 13 p668A-p668A, 1p. Supplement: S
Subject
Language
English
ISSN
10466673